A5073349915- Tuberculosis Research and Epidemiology
- HIV/AIDS Impact and Responses
- Data-Driven Disease Surveillance
- HIV/AIDS Research and Interventions
- Computational Drug Discovery Methods
- Pneumocystis jirovecii pneumonia detection and treatment
- Pharmaceutical Quality and Counterfeiting
- Diverse Scientific Research Studies
- Pneumonia and Respiratory Infections
- HIV, Drug Use, Sexual Risk
- Diagnosis and treatment of tuberculosis
Ministry of Public Health
2023
Sana'a University
2019
Diabetes mellitus (DM) is one of tuberculosis' (TB) ending barriers. TB patients with DM are at a higher risk than non-diabetes to develop complication, relapse and die. In Yemen, information on TB-DM comorbidity lacking. This study aimed determine the prevalence associated factors diabetes among National Tuberculosis Center (NTC) in Sana'a. A facility-based cross-sectional was conducted. All aged >15 years who attended NTC from July November 2021 were screened for DM. Socio-demographic...
Multidrug-resistant tuberculosis (MDR-TB) is a major challenge to ending TB occurrence by 2035. In Yemen, the 2011 survey showed an MDR-TB prevalence of 1.4% among new cases and 14.4% previously treated cases. The National Tuberculosis Control Program (NTCP) established four sentinel surveillance sites in 2013 monitor situation. NTCP situation.This study aimed assess performance determine its strengths weaknesses.We used updated Center for Diseases Prevention guidelines evaluating public...
Background: Developing Multi Drug-resistant TB (MDR-TB) is a threat facing the National Tuberculosis Control Program (NTCP) in Yemen. Four sentinel Surveillance sites were established 2014 to monitor situation and guide control.
Background: Drug-resistant tuberculosis (DR-TB) is a serious obstacle for successful TB control. The 2010–2011 Yemen DR-TB Survey showed an overall Multi (MDR-TB) prevalence of 2.9% that was 1.4% in newly- and 14.4% previously- treated patients. Surveillance system introduced December 2013 to improve detection management DR-TB.
<sec> <title>BACKGROUND</title> Multidrug-resistant tuberculosis (MDR-TB) is a major challenge to ending TB occurrence by 2035. In Yemen, the 2011 survey showed an MDR-TB prevalence of 1.4% among new cases and 14.4% previously treated cases. The National Tuberculosis Control Program (NTCP) established four sentinel surveillance sites in 2013 monitor situation. NTCP </sec> <title>OBJECTIVE</title> This study aimed assess performance determine its strengths weaknesses. <title>METHODS</title>...